Fig. 7From: Possible role of intravenous administration of mesenchymal stem cells to alleviate interstitial cystitis/bladder pain syndrome in a Toll-like receptor-7 agonist-induced experimental animal model in ratPossible therapeutic mechanism of infused MSCs. TLR7: Toll like receptor 7, MyD88: myeloid differentiation primary response 88, TGF-β: transforming growth factor beta, IRF7: interferon regulatory factor 7, IFN-β: interferon betaBack to article page